P-363 Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-Eligible Patients With Multiple Myeloma: A Pooled Analysis of Patients Aged ≥65 Years From Both PERSEUS and GRIFFIN Studies
Year: 2024
Type: conference-abstract
Authors: Paula Rodríguez-Otero, Peter M. Voorhees, Mario Boccadoro, Jacob Laubach, Hermann Einsele, Douglas W. Sborov, Meletios Dimopoulos, Annemiek Broijl, Roberto Mina, Andrew Spencer, Fredrik Schjesvold, Rebecca Silbermann, Francesca Gay, Luciano Costa, Aurore Perrot, Yanfang Liu, Jianping Wang, Anna Sitthi-Amorn, Robin Carson, Annelore Cortoos, Saad Usmani, Paul Richardson, Philippe Moreau, Pieter Sonneveld, Jonathan L. Kaufman
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402733893